Cognitive Performance Under Electroconvulsive Therapy (ECT) in ECT-Naive Treatment-Resistant Patients With Major Depressive Disorder

2017 ◽  
Vol 33 (2) ◽  
pp. 104-110 ◽  
Author(s):  
Christoph Ziegelmayer ◽  
Göran Hajak ◽  
Anne Bauer ◽  
Marion Held ◽  
Rainer Rupprecht ◽  
...  
2016 ◽  
Vol 205 ◽  
pp. 130-137 ◽  
Author(s):  
Peter C.R. Mulders ◽  
Philip F.P. van Eijndhoven ◽  
Joris Pluijmen ◽  
Aart H. Schene ◽  
Indira Tendolkar ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Aron T. Hill ◽  
Itay Hadas ◽  
Reza Zomorrodi ◽  
Daphne Voineskos ◽  
Faranak Farzan ◽  
...  

Abstract Electroconvulsive therapy (ECT) is a highly effective neuromodulatory intervention for treatment-resistant major depressive disorder (MDD). Presently, however, understanding of its neurophysiological effects remains incomplete. In the present study, we utilised resting-state electroencephalography (RS-EEG) to explore changes in functional connectivity, network topology, and spectral power elicited by an acute open-label course of ECT in a cohort of 23 patients with treatment-resistant MDD. RS-EEG was recorded prior to commencement of ECT and again within 48 h following each patient’s final treatment session. Our results show that ECT was able to enhance connectivity within lower (delta and theta) frequency bands across subnetworks largely confined to fronto-central channels, while, conversely, more widespread subnetworks of reduced connectivity emerged within faster (alpha and beta) bands following treatment. Graph-based topological analyses revealed changes in measures of functional segregation (clustering coefficient), integration (characteristic path length), and small-world architecture following ECT. Finally, post-treatment enhancement of delta and theta spectral power was observed, which showed a positive association with the number of ECT sessions received. Overall, our findings indicate that RS-EEG can provide a sensitive measure of dynamic neural activity following ECT and highlight network-based analyses as a promising avenue for furthering mechanistic understanding of the effects of convulsive therapies.


2015 ◽  
Vol 69 ◽  
pp. 94 ◽  
Author(s):  
Iraj Salehi ◽  
Seyed Mohammad Hosseini ◽  
Mohammad Haghighi ◽  
Leila Jahangard ◽  
Hafez Bajoghli ◽  
...  

1994 ◽  
Vol 165 (4) ◽  
pp. 506-509 ◽  
Author(s):  
Christopher F. Fear ◽  
Carl S. Littlejohns ◽  
Eryl Rouse ◽  
Paul McQuail

BackgroundThe induction agent propofol is known to reduce electroconvulsive therapy (ECT) seizure duration. It is assumed that outcome from depression is adversely affected by this agent. This study compares propofol and methohexitone as induction agents for ECT.MethodIn a prospective, randomised, double-blind study 20 subjects with major depressive disorder (DSM-III-R criteria) received propofol or methohexitone anaesthesia. The Hamilton Depression Rating Scale and Beck Depression Inventory were used to assess depression before therapy, at every third treatment, and at the end of therapy. Seizure duration was measured using the cuff technique.ResultsMean seizure durations (P < 0.01) and mean total seizure duration (P < 0.01) were shorter in the propofol group. There was no difference in outcome.ConclusionsUse of propofol may not adversely affect outcome from depression and it is not necessarily contraindicated as an induction agent for ECT. Our results should be interpreted cautiously, and larger studies are needed.


2018 ◽  
Vol 235 ◽  
pp. 169-175 ◽  
Author(s):  
Erika Martínez-Amorós ◽  
Ximena Goldberg ◽  
Verònica Gálvez ◽  
Aida de Arriba- Arnau ◽  
Virginia Soria ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document